Irodalom:
1. Yoo JW, Ryu JK, Lee SH, Woo SM, Park JK, Yoon WJ, Lee JK, Lee KH, Hwang JH, Kim YT, Yoon YB.:
Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis
in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008; 37: 366-70.
Gastro 2009.qxd 5/9/2009 1:42 PM Page 343
344 Gastro Update 2009
2. Lee KT, Lee DH, Yoo BM.: The prophylactic effect of somatostatin on post-therapeutic endoscopic
retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas.
2008; 37: 445-8.
3. Bai Y, Gao J, Zou DW, Li ZS.: Prophylactic octreotide administration does not prevent post-endoscopic
retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Pancreas.
2008; 37: 241-6.
4. Bai Y, Gao J, Zhang W, Zou D, Li Z.: Meta-analysis: allopurinol in the prevention of postendoscopic
retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther. 2008; 28: 557-64.
5. Zheng M, Chen Y, Bai J, Xin Y, Pan X, Zhao L: Meta-analysis of prophylactic allopurinol use in
post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2008; 37: 247-53.
6. Bai Y, Gao J, Shi X, Zou D, Li Z.: Prophylactic corticosteroids do not prevent post-ERCP pancreatitis:
a meta-analysis of randomized controlled trials. Pancreatology. 2008; 8: 504-9.
7. Bai Y, Gao F, Gao J, Zou DW, Li ZS.: Prophylactic Antibiotics Cannot Prevent Endoscopic Retrograde
Cholangiopancreatography-Induced Cholangitis: A Meta-Analysis. Pancreas. 2008; 26.
8. Buscaglia JM, Simons BW, Prosser BJ, Ruben DS, Giday SA, Magno P, Clarke JO, Shin EJ, Kalloo AN,
Kantsevoy SV, Gabrielson KL, Jagannath SB.: Severity of post-ERCP pancreatitis directly proportional to
the invasiveness of endoscopic intervention: a pilot study in a canine model. Endoscopy. 2008; 40: 506-12.
9. Buscaglia JM, Simons BW, Prosser BJ, Ruben DS, Giday SA, Magno P, Clarke JO, Shin EJ, Kalloo AN,
Kantsevoy SV, Gabrielson KL, Jagannath SB.: Etanercept, a TNF-alpha binding agent, is ineffective in
the prevention of post-ERCP pancreatitis in canines. JOP. 2008; 9: 456-67.
10. Ito K, Fujita N, Noda Y, Kobayashi G, Obana T, Horaguchi J, Takasawa O, Koshita S, Kanno Y.:
Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde
cholangio-pancreatography. World J Gastroenterol. 2008;14: 5595-600.
11. Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD.: A meta-analysis of rectal
NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008; 57: 1262-7.
12. Noble MD, Romac J, Vigna SR, Liddle RA: A pH-sensitive, neurogenic pathway mediates disease severity
in a model of post-ERCP pancreatitis. Gut. 2008 Nov; 57: 1566-71.
13. Nagar AB, Gorelick F.: Prevention of post-ERCP pancreatitis: a little antacid might go a long way. Gut.
2008; 57: 1492-3.
14. Petrov S.: Early Use of ERCP in Acute Biliary Pancreatitis with (out) Jaundice: An Unjaundiced View.
JOP. J. Pancreas (Online) 2009; 10: 1-7.
15. Oría A, Cimmino D, Ocampo C, Silva W, Kohan G, Zandalazini H, et al: Early endoscopic intervention
versus early conservative management in patients with acute gallstone pancreatitis and biliopancreatic
obstruction: a randomized clinical trial. Ann Surg 2007; 245: 10-7.
16. Moretti A, Papi C, Aratari A, Festa V, Tanga M, Koch M, Capurso L.: Is early endoscopic retrograde
cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of
randomized controlled trials. Dig Liver Dis. 2008; 40: 379-85.
17. Petrov MS.: ERCP versus conservative treatment in acute pancreatitis: meta-analysis or meta-confusion?
Dig Liver Dis. 2008; 40: 800-1.
18. Petrov MS, Uchugina AF, Kukosh MV.: Does endoscopic retrograde cholangiopancreatography reduce
the risk of local pancreatic complications in acute pancreatitis? A systematic review and metaanalysis.
Surg Endosc. 2008; 22: 2338-43.
19. Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, van Erpecum KJ, Gooszen HG.:
Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary
Gastro 2009.qxd 5/9/2009 1:42 PM Page 344
A hasnyálmirigy 345
pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg. 2008; 247: 250-7.
20. Uy MC, Ong JP, Sy PP, Banez VP: Systemic review on urgent endoscopic retrograde cholangiopancreatography
in acute gallstone pancreatitis without cholangitis. Gut 2008; 57 Suppl 2: P1478.
21. Van Santvoort HC, Besselink MG, de Vries AC, Cirkel G, Bollen TL, Fischer K, et al: Early ERCP is
only beneficial in predicted severe acute biliary pancreatitis in presence of cholestasis a prospective
multicenter study. Pancreatology 2008; 8: 337-8.
22. Baillie J.: Is ERCP headed for extinction? Am J Gastroenterol. 2008;103: 1888-90.
23. Baillie J.: Does every patient with acute gallstone pancreatitis require ERCP? Curr Gastroenterol Rep.
2008;10:147-9.
24. Baillie J.: Should urgent ERCP be performed in patients with acute biliary pancreatitis without acute
cholangitis? Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 484-5.
25. Behrns KE, Ashley SW, Hunter JG, Carr-Locke D.: Early ERCP for gallstone pancreatitis: for whom
and when? J Gastrointest Surg. 2008; 12: 629-33.
26. Petrov MS.: Early management of severe acute biliary pancreatitis: wind of change. Gut. 2008; 57: 1337-8.
27. Pandanaboyana S, Sim Y, Carole W, Hannah KJ, Christoph Kulli, Francesco MP, Iain ST: Management
Guidelines for Gallstone pancreatitis. Are the Targets Achievable? JOP. J Pancreas (Online) 2009; 10: 43-47.
28. Carnes ML, Romagnuolo J, Cotton PB.: Miss rate of pancreas divisum by magnetic resonance
cholangiopancreatography in clinical practice. Pancreas. 2008; 37: 151-3.
29. Kwan V, Loh SM, Walsh PR, Williams SJ, Bourke MJ.: Minor papilla sphincterotomy for pancreatitis
due to pancreas divisum. ANZ J Surg. 2008; 78: 257-61.
30. Chacko LN, Chen YK, Shah RJ.: Clinical outcomes and nonendoscopic interventions after minor papilla
endotherapy in patients with symptomatic pancreas divisum. Gastrointest Endosc. 2008; 68: 667-73.
31. Morgan KA, Romagnuolo J, Adams DB.: Transduodenal sphincteroplasty in the management of sphincter
of Oddi dysfunction and pancreas divisum in the modern era. J Am Coll Surg. 2008; 206: 908-14.
32. Gupta R, Lakhtakia S, Tandan M, Santosh D, Rao GV, Reddy DN.: Recurrent acute pancreatitis and
Wirsungocele. A case report and review of literature. JOP. 2008; 9: 531-3.
33. Fukatsu H, Kawamoto H, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ogawa T, Ishida E,
Okamoto Y, Okada H, Sakaguchi K.: Santorinicele in a patient with unresectable pancreatic cancer.
Intern Med. 2008; 47: 33-5.
34. Trevino JM, Wilcox CM, Varadarajulu S.: Endoscopic resection of minor papilla adenomas (with video).
Gastrointest Endosc. 2008; 68: 383-6.
35. Akatsu T, Aiura K, Takahashi S, Kameyama K, Kitajima M, Kitagawa Y.: Recurrent pancreatitis caused
by ampullary carcinoma and minor papilla adenoma in familial polyposis: report of a case. Surg Today.
2008; 38: 440-4.
36. Wakatsuki T, Irisawa A, Takagi T, Koyama Y, Hoshi S, Takenoshita S, Abe M, Ohira H.: Primary
adenocarcinoma of the minor duodenal papilla. Yonsei Med J. 2008; 49: 333-6.
37. Linder S, Söderlund C.: Factors influencing the use of precut technique at endoscopic sphincterotomy.
Hepatogastroenterology. 2007; 54: 2192-7.
38. Weber A, Roesch T, Pointner S, Born P, Neu B, Meining A, Schmid RM, Prinz C.: Transpancreatic precut
sphincterotomy for cannulation of inaccessible common bile duct: a safe and successful technique.
Pancreas. 2008; 36: 187-91.
39. Naitoh I, Nakazawa T, Ohara H, Ando T, Hayashi K, Okumura F, Togawa S, Kitajima Y, Ban T, Miyabe K,
Gastro 2009.qxd 5/9/2009 1:42 PM Page 345
346 Gastro Update 2009
Ueno K, Yamashita H, Joh T, Sano H.: A case of obstructive jaundice caused by impaction of a pancreatic
stone in the papilla for which a needle knife precut papillotomy was effective. JOP. 2008; 9: 520-5.
40. Fatima J, Baron TH, Topazian MD, Houghton SG, Iqbal CW, Ott BJ, Farley DR, Farnell MB, Sarr MG.:
Pancreaticobiliary and duodenal perforations after periampullary endoscopic procedures: diagnosis and
management. Arch Surg. 2007; 142: 448-54.
41. Knudson K, Raeburn CD, McIntyre RC Jr, Shaw RJ, Chen YK, Brown WR, Stiegmann G.: Management
of duodenal and pancreaticobiliary perforations associated with periampullary endoscopic procedures.
Am J Surg. 2008; 196: 975-81.
42. Ono Y, Kaneko K, Tainaka T, Sumida W, Ando H.: Pancreaticobiliary maljunction without bile duct
dilatation in children: distinction from choledochal cyst. J Pediatr Gastroenterol Nutr. 2008; 46: 555-60.
43. Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Matsukawa M.: Pancreas divisum in pancreaticobiliary
maljunction. Hepatogastroenterology. 2008; 55: 249-53.
44. Petrasek J, Hucl T, Spicak J.: Pancreaticobiliary malunion and incomplete pancreas divisum: an unusu
al cause of common bile duct obstruction. Adv Med Sci. 2008; 53: 6-10.
45. Terui K, Yoshida H, Kouchi K, Hishiki T, Saito T, Mitsunaga T, Takenouchi A, Tsuyuguchi T, Yamaguchi T,
Ohnuma N.: Endoscopic sphincterotomy is a useful preoperative management for refractory pancreatitis
associated with pancreaticobiliary maljunction. J Pediatr Surg. 2008; 43: 495-9.
46. Judah JR, Draganov PV.: Intraductal biliary and pancreatic endoscopy: an expanding scope of possibility.
World J Gastroenterol. 2008;14: 3129-36.
47. Athanassiadou P, Grapsa D.: Value of endoscopic retrograde cholangiopancreatography-guided brushings
in preoperative assessment of pancreaticobiliary strictures: what’s new? Acta Cytol. 2008; 52: 24-34.
48. Pap Á, Tarpay Á, Burai M, Nagy T, Bak M.: Close cooperation of endoscopist and cytologist can
increase sensitivity of intraductal brush cytology at ERCP. Pancreatology. 2008; 8: 387.
49. Schönleben F, Allendorf JD, Qiu W, Li X, Ho DJ, Ciau NT, Fine RL, Chabot JA, Remotti HE, Su GH.:
Mutational analyses of multiple oncogenic pathways in intraductal papillary mucinous neoplasms of
the pancreas. Pancreas. 2008; 36: 168-72.
50. Sahani DV, Lin DJ, Venkatesan AM, Sainani N, Mino-Kenudson M, Brugge WR, Fernandez-Del-Castillo C.:
Multidisciplinary Approach to Diagnosis and Management of Intraductal Papillary Mucinous Neoplasms
of the Pancreas. Clin Gastroenterol Hepatol. 2008.
51. Abe N, Sugiyama M, Suzuki Y, Yamaguchi T, Mori T, Atomi Y.: Preoperative endoscopic pancreatic stenting:
a novel prophylactic measure against pancreatic fistula after distal pancreatectomy. J Hepatobiliary
Pancreat Surg. 2008;15: 373-6.
52. Fischer CP, Bass B, Fahy B, Aloia T.: Transampullary pancreatic duct stenting decreases pancreatic fistula
rate following left pancreatectomy. Hepatogastroenterology. 2008; 55: 244-8.
53. Okamoto T, Gocho T, Futagawa Y, Fujioka S, Yanaga K, Ikeda K, Kakutani H, Tajiri H.: Usefulness of
pancreatic duct stenting prior to surgery as a guide to decide the feasibility of limited pancreatic resection.
Dig Surg. 2008; 25: 175-8.
54. Pelaez-Luna M, Vege SS, Petersen BT, Chari ST, Clain JE, Levy MJ, Pearson RK, Topazian MD, Farnell
MB, Kendrick ML, Baron TH.: Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical
and imaging characteristics and outcomes in a cohort of 31 cases. Gastrointest Endosc. 2008; 68: 91-7.
55. Lawrence C, Howell DA, Stefan AM, Conklin DE, Lukens FJ, Martin RF, Landes A, Benz B.: Disconnected
pancreatic tail syndrome: potential for endoscopic therapy and results of long-term follow-up. Gastrointest
Endosc. 2008; 67: 673-9.
56. Trudzinski FC, Rädle J, Treiber G, Kramm T, Sybrecht GW.: Massive pleural effusion complicating
Gastro 2009.qxd 5/9/2009 1:42 PM Page 346
A hasnyálmirigy 347
chronic pancreatitis. Treatment by endoscopic closure of a pancreatic-mediastinal fistula. Dtsch Med
Wochenschr. 2008; 133: 2507-9.
57. Okada K, Furuuchi T, Tamada T, Sasaki T, Suwa T, Shatari T, Takenaka Y, Hori M, Sakuma M.:
Pancreatobiliary fistula associated with an intraductal papillary-mucinous pancreatic neoplasm
manifesting as obstructive jaundice: report of a case. Surg Today. 2008; 38: 371-6.
58. Simmons DT, Baron TH, LeRoy A, Petersen BT.: Percutaneous pancreatography for treatment of
complicated pancreatic duct strictures. Pancreatology. 2008; 8: 194-8.
59. Laukkarinen J, Lämsä T, Nordback I, Mikkonen J, Sand J.: A novel biodegradable pancreatic stent for
human pancreatic applications: a preclinical safety study in a large animal model. Gastrointest Endosc.
2008; 67: 1106-12.
60. Cai ZZ, Liu Y, Liu JL, Man XH, Wu HY, Jin J, Jin ZD, Gong YF, Gao J, Li ZS.: An experiment of 125I
radioactive pancreatic duct stents implanted in the pancreatic ducts of pigs. Zhonghua Nei Ke Za Zhi.
2008; 47: 300-3.
61. Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, Domschke W, Schober O,
Heindel W, Pohle T, Juergens KU.: Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic
lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal
ultrasonography and abdominal ultrasound. Eur J Nucl Med Mol Imaging. 2008; 35: 1775-85.
62. Sugimoto M, Yasuda H, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Takenoue T,
Yamamoto S, Watayo Y, Yagawa Y, Tsuchiya T.: Virtual CO2 MDCT pancreatography: a new feasible
technique for minimally invasive pancreatectomy in intraductal papillary mucinous neoplasms.
Hepatogastroenterology. 2008; 55: 270-4.
63. Sai JK, Suyama M, Kubokawa Y, Watanabe S.: Diagnosis of mild chronic pancreatitis (Cambridge
classification): comparative study using secretin injection-magnetic resonance cholangiopancreatography
and endoscopic retrograde pancreatography. World J Gastroenterol. 2008; 14: 1218-21.
64. Balci NC, Momtahen AJ, Akduman EI, Alkaade S, Bilgin M, Burton FR.: Diffusion-weighted MRI of the
pancreas: correlation with secretin endoscopic pancreatic function test (ePFT). Acad Radiol. 2008;15: 1264-8.
65. Testoni PA, Mariani A, Curioni S, Zanello A, Masci E.: MRCP-secretin test-guided management of
idiopathic recurrent pancreatitis: long-term outcomes. Gastrointest Endosc. 2008; 67: 1028-34.
66. Al-Haddad M, Wallace MB.: Diagnostic approach to patients with acute idiopathic and recurrent
pancreatitis, what should be done? World J Gastroenterol. 2008; 14: 1007-10.
67. Barthet M, Lamblin G, Gasmi M, Vitton V, Desjeux A, Grimaud JC.: Clinical usefulness of a treatment
algorithm for pancreatic pseudocysts. Gastrointest Endosc. 2008; 67: 245-52.
68. Varadarajulu S, Christein JD, Tamhane A, Drelichman ER, Wilcox CM.: Prospective randomized trial
comparing EUS and EGD for transmural drainage of pancreatic pseudocysts (with videos). Gastrointest
Endosc. 2008; 68: 1102-11.
69. Kamisawa T, Imai M, Yui Chen P, Tu Y, Egawa N, Tsuruta K, Okamoto A, Suzuki M, Kamata N.: Strategy
for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008; 37: e62-7.
70. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, Park SW, Shimosegawa T, Lee K, Ito T,
Nishimori I, Notohara K, Naruse S, Ko SB, Kihara Y: Research Committee of Intractable Pancreatic
Diseases provided by the Ministry of Health, Labour and Welfare of Japan and the Korean Society of
Pancreatobiliary Diseases.: Asian diagnostic criteria for autoimmune pancreatitis: consensus of the
Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008; 43: 403-8.
71. Ryu JK, Chung JB, Park SW, Lee JK, Lee KT, Lee WJ, Moon JH, Cho KB, Kang DW, Hwang JH, Yoo KS,
Yoo BM, Lee DH, Kim HK, Moon YS, Lee J, Lee HS, Choi HS, Lee SK, Kim YT, Kim CD, Kim SJ, Hahm JS,
Yoon YB.: Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide
study. Pancreas. 2008; 37: 377-85.
